AI Test Pinpoints More Cancers Targeted by Astra, Glaxo Drugs

Advertisement
By John Lauerman, Bloomberg | Updated: 16 April 2019 14:04 IST

Using artificial intelligence to pinpoint tumour cells with reduced ability to repair their own DNA can help identify tens of thousands of patients who would benefit from treatment with drugs from AstraZeneca and GlaxoSmithKline, researchers said.

Analysing genetic tests with a machine-learning algorithm helps target cancers that are vulnerable to treatment with drugs called PARP inhibitors, according to a study from scientists at Harvard Medical School in Boston and the UK's University of Cambridge.

Advertisement

Oncology is among the fastest-growing fields in the pharmaceutical industry, with an armada of newly developed treatments sending annual sales surging to about $133 billion. Doctors and scientists are searching for more hints of how to deploy the costly drugs that sometimes shrink tumours in just a fraction of patients.

Oncologists often determine whether patients will receive PARP inhibitors like Astra's Lynparza or Glaxo's Zejula by testing for flaws in certain gene mutations that block cells from fixing their own DNA using a specific mechanism. Yet many tumours without those mutations may also have the same genetic repair deficit, but are harder to find because there's no specific gene test.

Advertisement

The algorithm finds patterns in tumours that show whether they have a deficiency in homologous DNA repair, which makes them susceptible to treatment by PARP inhibitors, researchers led by Harvard research fellow Doga Gulhan said Monday in the journal Nature Genetics. The technique can be applied to genetic tests that are already performed on many tumours, the researchers said.

Of 270,000 breast cancers diagnosed in 2018, about 13,500 to 27,000 were attributed to so-called BRCA mutations, and thus could be targeted with PARP inhibitors, the researchers said. Using computer simulation analysis, they identified as many as 54,000 more with normal BRCA genes that had defects in homologous repair, and might be treated with the new cancer drugs.

Advertisement

Analysts estimate Lynparza sales of $1.1 billion this year, and Zejula sales of $314 million. Clovis Oncology Inc.'s Rubraca, another PARP inhibitor, is estimated to sell $147 million.

© 2019 Bloomberg LP

 

Get your daily dose of tech news, reviews, and insights, in under 80 characters on Gadgets 360 Turbo. Connect with fellow tech lovers on our Forum. Follow us on X, Facebook, WhatsApp, Threads and Google News for instant updates. Catch all the action on our YouTube channel.

Further reading: Cancer
Advertisement

Related Stories

Popular Mobile Brands
  1. BSNL Voice-Only Prepaid Plans With Unlimited Calls Launched in India
  2. Motorola Edge 70 Neo All Set to Launch in India on This Date
  3. Philips TAB4304/94 Soundbar and Three Bluetooth Speakers Debut in India
  4. WhatsApp Android Beta Gets Sticker Reactions for Messages: How It Works
  5. Apple Revamps the Maps Experience for India With These New Features
  6. Google Gemini Tasks Rolls Out to Free Users in India, US and Other Markets
  7. Here's How You Can Play GTA 6 Early on PS5 and Xbox Series S/X
  8. Vivo Y05s Could Be a Rebranded Vivo Y05 4G: Here's How We Know
  1. Vivo Y05s Google Play Console Listing Suggests It Could Be a Rebranded Vivo Y05 4G
  2. WhatsApp Message Sticker Reactions Feature Reportedly Rolling Out to Android Beta Users
  3. BSNL Voice-Only Prepaid Plans With Unlimited Calls Launched in India: Price, Offers, Benefits
  4. MEXC Pulls the Plug on Visa-Linked Crypto Card Service Within Three Months After Launch
  5. Solana Foundation Acquires Majority Stake in Crypto Data Platform CoinGecko
  6. Grand Theft Auto 6 Review Roundup: Rockstar's Open World Title Becomes Highest Rated Game of All Time
  7. Philips TAB4304/94 Soundbar and Three Bluetooth Speakers Launched in India: Price, Features
  8. Google Gemini Tasks Rolls Out to Free Users in India: Here's What You Need to Know
  9. Meta Tests Instagram Direct App With Messaging Features for Users Without Instagram Accounts
  10. Can AI Run a Factory? Siemens Launches Eigen Engineering Agent in India
Download Our Apps
Available in Hindi
© Copyright Red Pixels Ventures Limited 2026. All rights reserved.